Dr Tim Hirst | Chairman And Chief Executive Officer
GPN Vaccines

Dr Tim Hirst, Chairman And Chief Executive Officer, GPN Vaccines

Tim Hirst is based in Canberra, Australia and is an experienced angel investor, entrepreneur and company director with a particularly interest in the medtech, biotech and pharmaceuticals sectors.  He a member of a number angel investment groups in Australia (in Adelaide, Canberra and Sydney) and the US (New York and Palo Alto) in which he specialises in undertaking extensive scientific due diligence. During his earlier academic career he was an internationally acknowledged molecular microbiologist working on bacterial toxins, immune modulation and vaccine development, publishing over 150 research articles, reviews and book chapters.  He was Professor and Head of Microbiology at the University of Bristol UK and Vice-President & Deputy Vice-Chancellor at the University of Sydney, before moving into the venture capital industry as CEO of ANU Connect Ventures – a $30M pre-seed investment fund. He is currently the Executive Chairman of Gamma Vaccines Pty Ltd – a company developing improved vaccines for influenza and pneumococcal disease and Chairman of OzStar Therapeutics Pty Ltd – a company focussed on an adjunctive treatment for type 2 diabetes. He is also an Honorary Professor in the School of Biological Sciences at the University of Adelaide, Australia.


April 16 Day 2 - 10 Co-conferences @ 17:10

Understanding what corporate funders and VCs are looking before they invest

April 17 Day 3 - 10 Co-conferences & Plenary @ 09:55

A new broad-spectrum vaccine against Streptococcus pneumoniae

last published: 11/Apr/19 16:05 GMT

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071